Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL6 | P41182 | 6/20 | 0.47 |
| ▸ | BCOR | Q6W2J9 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 7/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | AURKA | O14965 | 1/20 | 0.44 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30832785 | 0.76 | BCL6 (0.51) | BCL6BCORMAPTALDH1A1HPGD | |
| SCHEMBL20773220 | 0.76 | BCL6 (0.51) | BCL6BCORMAPTALDH1A1HPGD | |
| SCHEMBL2612577 | 0.72 | MAPT (0.56) | MAPTALDH1A1HPGDMAPK1HTT | |
| SCHEMBL30101406 | 0.72 | ADORA2A (0.55) | MAPTALDH1A1HPGDMAPK1HTT | |
| SCHEMBL29963397 | 0.72 | ADORA2A (0.55) | MAPTALDH1A1HPGDMAPK1HTT | |
| SCHEMBL11604826 | 0.72 | P2RY2 (0.54) | MAPTALDH1A1HPGDMAPK1HTT | |
| SCHEMBL11413805 | 0.72 | ADORA2A (0.55) | MAPTALDH1A1HPGDMAPK1HTT | |
| SCHEMBL11602772 | 0.71 | DHODH (0.49) | MAPTMAPK1HTTKMT2AMEN1 | |
| SCHEMBL7061696 | 0.71 | GNG2 (0.52) | MAPTALDH1A1HPGDMAPK1HTT | |
| SCHEMBL9308589 | 0.71 | MAPK1 (0.50) | MAPTALDH1A1HPGDMAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7514569-B2 | red pigments has superior dispersibility in binder, non-flocculated, produce a desired hue; contains anthraquinone group; printing inks, paints, colorants for various plastics, toner | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2009-04-07 | — | — | US | disclosed |
| US-7514569-B2 | red pigments has superior dispersibility in binder, non-flocculated, produce a desired hue; contains anthraquinone group; printing inks, paints, colorants for various plastics, toner | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2009-04-07 | — | — | US | disclosed |
| US-20070135639-A1 | Benzimidazolone compound | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-06-14 | — | — | US | disclosed |
| US-20070135639-A1 | Benzimidazolone compound | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135639-A1 | Benzimidazolone compound | CDK20, CDK1, CDK2 | BCL6 270/4885BCOR 1532/4885MAPT 3625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.